Literature DB >> 12532577

Diagnosis of typhoid fever by Dot enzyme immunoassay in an endemic region.

E Khan1, I Azam, S Ahmed, R Hassan.   

Abstract

OBJECTIVE: To compare the results of Dot Enzyme Immunoassay (EIA) and concomitantly performed blood culture for the diagnosis of typhoid fever.
METHODS: The results of Dot Enzyme Immunoassay (EIA) of patients who also had blood cultures/bone marrow culture performed at the same time were analyzed. The period of study spans between April 1997-September 1997.
RESULTS: A total of 1760 Dot Enzyme Immunoassays were performed from April 1997 to September 1997. Of these, only 128 (7.2%) cases had concomitantly performed blood/bone marrow cultures. Therefore, the study was narrowed down to these 128 cases. Sixty-nine cases were culture positive for S. typhi. Of these culture proven cases, IgM antibodies by Dot EIA were positive only in 49 (71%) cases while 20 (28.9%) of culture proven cases remained negative for IgM antibodies.
CONCLUSION: Taking blood/bone marrow culture as gold standard, the sensitivity of Dot EIA was found to be 71% while specificity was found to be 43%. The predictive value of the positive test was found to be 59.7% and that of a negative test was found to be 56.5%.

Entities:  

Mesh:

Year:  2002        PMID: 12532577

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Salmonella enterica serovar Typhi O:1,9,12 polysaccharide-protein conjugate as a diagnostic tool for typhoid fever.

Authors:  Jessica Zuñiga; Luis Lillo; Junghee J Shin; Rajya L Machavarapu; Teresa Quiroga; Manuela Goycoolea; Betty Matsuhiro; L Aron-Hott; Henry P Godfrey; Felipe C Cabello
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Typhoid Fever.

Authors:  Christopher M. Parry
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

Review 3.  Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever.

Authors:  Lalith Wijedoru; Sue Mallett; Christopher M Parry
Journal:  Cochrane Database Syst Rev       Date:  2017-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.